WVP
YTEN

Worth Venture Partners’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Worth Venture Partners’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,358
Closed -$427K – 182
2022
Q1 		$427K Buy
3,358
+38
+1% +$3.92K 0.2% 89
2021
Q4 		$392K Hold
3,320
– – 0.19% 89
2021
Q3 		$477K Hold
3,320
– – 0.21% 92
2021
Q2 		$680K Sell
3,320
-401
-11% -$89.3K 0.25% 80
2021
Q1 		$1.12M Buy
+3,721
New +$1.26M 0.54% 54
2020
Q4 		– Sell
-1,647
Closed -$307K – 132
2020
Q3 		$307K Buy
+1,647
New +$243K 0.25% 78

Other funds holding YTEN

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $770M AUM 18.25% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Worth Venture Partners's YTEN Position: Q2 2022 in Review

Worth Venture Partners sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2022, closing a stake of 3,358 shares — an estimated $427K sold.

Worth Venture Partners first reported a position in YTEN in Q3 2020 and held it in 6 quarters. The position peaked at $1.12M in Q1 2021. 12 funds tracked by Wall St. Rank hold YTEN as of Q2 2022.

  • Worth Venture Partners reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Worth Venture Partners sold 3,358 Yield10 Bioscience, Inc. Common Stock shares in Q2 2022, an estimated $427K.
  • Worth Venture Partners first reported a position in Yield10 Bioscience, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Worth Venture Partners's Yield10 Bioscience, Inc. Common Stock position peaked at $1.12M in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2022.

Based on Worth Venture Partners's 13F filing for Q2 2022, filed 15 Aug 2022.